Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
191.31
+1.04 (0.55%)
At close: Oct 30, 2026, 4:00 PM EDT
193.00
+1.69 (0.88%)
After-hours: Oct 30, 2026, 7:41 PM EDT

Revolution Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,768-1,131-600.09-436.37-248.71-187.09
Depreciation & Amortization
17.6815.6610.728.218.566.23
Other Amortization
0.40.91.11.11.11.1
Loss (Gain) From Sale of Assets
0.030.030.120.050.020.12
Loss (Gain) From Sale of Investments
-17.83-27.83-44.57-22.21-3.083.01
Stock-Based Compensation
218.77118.3979.261.7731.220.72
Other Operating Activities
239.3839.59-4.320.12--
Change in Accounts Receivable
--1.253.421.260.46
Change in Accounts Payable
30.939.54-6.4732.477.292.24
Change in Unearned Revenue
----4.46-14.47-1.66
Change in Other Net Operating Assets
55.8977.296.389.23-7.147.68
Operating Cash Flow
-1,223-897.74-557.44-350.57-224.4-147.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.1-15.99-10.31-7.73-10.82-6.53
Investment in Securities
-1,377134.05-544.09-334.87-13.3-135.59
Investing Cash Flow
-1,386118.06-554.39-342.6-24.12-142.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
2,298377.09863.71392.39301.39294.6
Repurchase of Common Stock
----4.03--
Other Financing Activities
238.71244.4495.71840.830.04-0.42
Financing Cash Flow
3,023621.52959.411,229301.43294.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
413.94-158.16-152.42536.0352.924.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,232-913.73-567.74-358.3-235.22-153.71
Free Cash Flow Growth
------
Free Cash Flow Margin
----3094.14%-664.83%-522.99%
Free Cash Flow Per Share
-6.22-4.81-3.38-3.17-2.92-2.11
Levered Free Cash Flow
-711.61-523.28-347.69-163.95-132.84-84.69
Unlevered Free Cash Flow
-674.52-508.13-347.69-163.95-132.84-84.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
86.8286.820.4136.75-13.498.72
SEC Filings: 10-K · 10-Q